Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Tamsulosin Therapy for Lower Urinary Tract Symptoms

Mechanism and Indications

  • Tamsulosin is considered first-line pharmacological treatment for male lower urinary tract symptoms (LUTS) due to its rapid onset of action, good efficacy, and relatively low rate of adverse events, as recommended by the European Association of Urology 1, 2

Effects on Urinary Symptoms

  • Tamsulosin reduces urgency in patients with benign prostatic hyperplasia (BPH), as reported by the European Urology association 1

Common Side Effects of Tamsulosin

  • The most frequently reported adverse effects of tamsulosin include dizziness, as reported by the European Urology association 1
  • Orthostatic hypotension is a common side effect of tamsulosin, according to the European Urology association 1
  • Asthenia (weakness) is a side effect of tamsulosin, as noted by the European Urology association 2
  • Rhinitis (nasal congestion) is a side effect of tamsulosin, as reported by the Journal of Clinical Oncology 3
  • Ejaculatory dysfunction is a side effect of tamsulosin, as reported by the European Urology association 1

Use in Clinical Practice

  • Tamsulosin is specifically recommended for treating urinary symptoms in men with BPH, as recommended by the American Cancer Society 4
  • For patients with urinary retention, tamsulosin may be prescribed to improve bladder emptying, as reported by the Journal of Clinical Oncology 3
  • In prostate cancer survivors with urinary symptoms, tamsulosin is recommended to address slow urinary stream, as recommended by the American Cancer Society 4

Special Considerations

  • Tamsulosin does not affect prostate size or prevent acute urinary retention or the need for surgery in the long term, as reported by the European Urology association 1
  • It is most effective in patients with smaller prostates (<40 ml), as noted by the European Urology association 1
  • Patients undergoing cataract surgery should inform their ophthalmologist about tamsulosin use due to risk of intraoperative floppy iris syndrome, as reported by the European Urology association 1